Literature DB >> 15822948

Transition state studies on the dioxirane-mediated asymmetric epoxidation via kinetic resolution and desymmetrization.

Jon C Lorenz1, Michael Frohn, Xiaoming Zhou, Jian-Rong Zhang, Yong Tang, Christopher Burke, Yian Shi.   

Abstract

This paper describes an efficient kinetic resolution process of trisubstituted cyclic olefins via a chiral dioxirane generated in situ from a fructose-derived ketone and Oxone. The substrates presented include a variety of 1,3-disubstituted and 1,6-disubstituted cyclohexenes with the stereogenic centers at allylic positions. A sequential desymmetrization and kinetic resolution of 1,4-cyclohexadienes by the chiral dioxirane was also found to be feasible. The initially formed monoepoxides can be kinetically resolved by continuing the reaction, leading to the increase or decrease of the ee values of monoepoxides depending on the diene systems. In some cases, a prochiral directing group is not required and the first formed epoxide stereoselectively directs the second epoxidation. When the coupled desymmetrization and kinetic resolution is used synergistically, high enantiopurity can be obtained for an epoxide from an intrinsically less enantioselective substrate. The observed absolute and relative stereochemistry as well as the changing optical purity can be effectively rationalized by transition state analysis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15822948     DOI: 10.1021/jo048217p

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  2 in total

1.  Highly enantioselective CH oxidation of vic-Diols with Shi's oxazolidinone dioxiranes.

Authors:  Kavitha Jakka; Cong-Gui Zhao
Journal:  Org Lett       Date:  2006-07-06       Impact factor: 6.005

2.  A method for the preparation of differentiated trans-1,2-diol derivatives with enantio- and diastereocontrol.

Authors:  Sang Min Lim; Nicholas Hill; Andrew G Myers
Journal:  J Am Chem Soc       Date:  2009-04-29       Impact factor: 15.419

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.